Literature DB >> 11409907

Non-infectious complications of transfusion therapy.

P L Perrotta1, E L Snyder.   

Abstract

Blood transfusion is considered safe when the infused blood is tested using state of the art viral assays developed over the past several decades. Only rarely are known viruses like HIV and hepatitis C transmitted by transfusion when blood donors are screened using these sensitive laboratory tests. However, there are a variety of transfusion risks which still remain that cannot be entirely eliminated, many of which are non-infectious in nature. Predominantly immune-mediated complications include the rapid intravascular or slow extravascular destruction (hemolysis) of transfused red cells or extravascular removal of platelets by pre-formed antibodies carried by the transfusion recipient. Alternatively, red cells can be damaged when exposed to excessive heat or incompatible intravenous fluids before or during the transfusion. Common complications of blood transfusion that at least partly involve the immune system include febrile non-hemolytic and allergic reactions. While these are usually not life-threatening, they can hamper efforts to transfuse a patient. Other complications include circulatory overload, hypothermia and metabolic disturbances. Profound hypotensive episodes have been described in patients on angiotensin-converting enzyme (ACE) inhibitors who receive platelet transfusions through bedside leukoreduction filters. These curious reactions appear to involve dysmetabolism of the vasoactive substance bradykinin. Products contaminated by bacteria during blood collection and transfused can cause life-threatening septic reactions. A long-term complication of blood transfusion therapy unique to chronically transfused patients is iron overload. Less common - but serious - reactions more specific to blood transfusion include transfusion-associated graft-versus-host disease and transfusion-associated acute lung injury. Many of these complications of transfusion therapy can be prevented by adhering to well-established practice guidelines. In addition, individuals who administer blood transfusions should recognize these complications in order to be able to quickly provide appropriate treatment. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409907     DOI: 10.1054/blre.2001.0151

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  33 in total

Review 1.  Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion.

Authors:  Giel J C G M Bosman; Mark Stappers; Vera M J Novotný
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  What every physician should know about transfusion reactions.

Authors:  Suzanne Bakdash; Mark H Yazer
Journal:  CMAJ       Date:  2007-07-17       Impact factor: 8.262

Review 3.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Authors:  Terrence L Geiger; Scott C Howard
Journal:  Transfus Med Rev       Date:  2007-01

4.  Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.

Authors:  Gjin Ndrepepa; Dritan Keta; Stefanie Schulz; Julinda Mehilli; Anette Birkmeier; Franz-Josef Neumann; Albert Schömig; Adnan Kastrati
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

5.  In vitro lysis and acute transfusion reactions with hemolysis caused by inappropriate storage of canine red blood cell products.

Authors:  J Patterson; A Rousseau; R J Kessler; U Giger
Journal:  J Vet Intern Med       Date:  2011-05-25       Impact factor: 3.333

6.  Evaluation of Four Bedside Test Systems for Card Performance, Handling and Safety.

Authors:  Felix Giebel; Susanne M Picker; Birgit S Gathof
Journal:  Transfus Med Hemother       Date:  2007-12-03       Impact factor: 3.747

7.  Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study.

Authors:  David Tanne; Noa Molshatzki; Oleg Merzeliak; Rakefet Tsabari; Maya Toashi; Yvonne Schwammenthal
Journal:  BMC Neurol       Date:  2010-04-09       Impact factor: 2.474

8.  Preparation of ultrapure bovine and human hemoglobin by anion exchange chromatography.

Authors:  Guoyong Sun; Andre F Palmer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-02-26       Impact factor: 3.205

9.  Intraoperative blood transfusion of one or two units of packed red blood cells is associated with a fivefold risk of stroke in patients undergoing elective carotid endarterectomy.

Authors:  Chen Rubinstein; Daniel L Davenport; Rebekah Dunnagan; Sibu P Saha; Victor A Ferraris; Eleftherios S Xenos
Journal:  J Vasc Surg       Date:  2013-02       Impact factor: 4.268

10.  The Severity of Injury and the Extent of Hemorrhagic Shock Predict the Incidence of Infectious Complications in Trauma Patients.

Authors:  Thomas Lustenberger; Matthias Turina; Burkhardt Seifert; Ladislav Mica; Marius Keel
Journal:  Eur J Trauma Emerg Surg       Date:  2009-03-16       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.